UPSC CMS result 2020 declared at upsc.gov.in; interview, personality test form available from 24 November

-

The UPSC CMS result 2020 has been declared by the Union Public Services Commission (UPSC) on its website. Candidates who had appeared for the UPSC combined medical services (CMS) written exam can check their score and qualifying status at upsc.gov.in.

UPSC CMS written exam 2020 was conducted by the Commission on 22 October. Those who have qualified the exam will have to appear for interview and personality test. Shortlisted candidates will have to fill the detailed application form (DAF) online between 24 November and 4 December up to 6 pm.

The UPSC CMS result 2020 has been released in PDF format.

At the time of filling DAF, candidates will also be required to submit scanned copies of relevant certificates and documents in support of their eligibility or claim for reservation. At the time of personality test, shortlisted candidates will be required to carry all the relevant certificates relating to age and educational qualifications.

The detailed schedule of interview round for candidates will soon be uploaded on UPSC's official website.

As per the UPSC notification, the mark sheet of candidates who have not qualified the CMS exam will be uploaded on the official website of the commission after the publication of final result. The score card will be available on the website for a period of 30 days.

Steps to check UPSC CMS result 2020:

Step 1: Go to the Union Public Service Commission's official website: upsc.gov.in.
Step 2: On the homepage, tap on Written Results link and then on a new page, click on Examination Written Results.
Step 3: Tap on the link that reads, "Combined Medical Services Examination, 2020."
Step 4: A PDF document will open. Scroll down and check for your roll number.

Here is the direct link to check UPSC CMS result 2020



from Firstpost India Latest News https://ift.tt/38FOMvI
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more